FindTrial
Sign In

A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer.

A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer. - A clinical study to evaluate the efficacy of BMA for the patients of PCa.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000015126
Enrollment
Unknown
Registered
2014-09-12
Start date
2014-08-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Sponsors

Department of Urology, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: patients of prostate cancer

Exclusion criteria

Exclusion criteria: patients who don't want to participate in this study

Design outcomes

Primary

MeasureTime frame
SRE QOL—

Secondary

MeasureTime frame
bone fracture pain—

Countries

Japan

Contacts

Public ContactTakeo Kosaka

Keio University School of Medicine Department of Urology

takemduro@a6.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026